![](/images/graphics-bg.png)
Multiantibody Strategies for HIV
Joint Authors
Zeitlin, Larry
Whaley, Kevin J.
Hiatt, Andrew
Source
Clinical and Developmental Immunology
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-06-06
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Vaccination strategies depend entirely on the appropriate responsiveness of our immune system against particular antigens.
For this active immunization to be truly effective, neutralizing antibodies (nAbs) need to efficiently counter the infectivity or propagation of the pathogen.
Some viruses, including HIV, are able to take advantage of this immune response in order to evade nAbs.
This review focuses on viral immune evasion strategies that result directly from a robust immune response to infection or vaccination.
A rationale for multi-Ab therapy to circumvent this phenomenon is discussed.
Progress in the formulation, production, and regulatory approval of monoclonal antibodies (mAbs) is presented.
American Psychological Association (APA)
Hiatt, Andrew& Zeitlin, Larry& Whaley, Kevin J.. 2013. Multiantibody Strategies for HIV. Clinical and Developmental Immunology،Vol. 2013, no. 2013, pp.1-11.
https://search.emarefa.net/detail/BIM-486800
Modern Language Association (MLA)
Hiatt, Andrew…[et al.]. Multiantibody Strategies for HIV. Clinical and Developmental Immunology No. 2013 (2013), pp.1-11.
https://search.emarefa.net/detail/BIM-486800
American Medical Association (AMA)
Hiatt, Andrew& Zeitlin, Larry& Whaley, Kevin J.. Multiantibody Strategies for HIV. Clinical and Developmental Immunology. 2013. Vol. 2013, no. 2013, pp.1-11.
https://search.emarefa.net/detail/BIM-486800
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-486800